News and Events

News and Events at The Naviaux Lab


   news_and_events

News and Events

Upcoming Events 

  1. September 9-10, 2022–“Cell Danger Response, Mitochondria, and the Healing Cycle”, Pediatric Brain Summit, Rancho Palos Verdes, CA
  2. September 30, 2022–“The cell danger response, mitochondria, and ATP signaling in autism spectrum disorder”, UCSD Genetics Noon conference series, La Jolla, CA
  3. October 14-16, 2022–“Mitochondria and Autism—Emerging therapies and clinical trials”, TACA Annual Meeting, Costa Mesa, CA.

Past Events

  1.  June 8-11, 2022—“Autism and Mitochondria—2000-2022”.  United Mitochondrial Disease Foundation (UMDF) Annual Symposium, Phoenix, AZ
  2. December 12, 2021—Zoom lecture, “Emerging therapeutics for ASD—Shifting paradigms and improving outcomes with mitochondrial cell danger response (CDR) and healing cycle systems research”, Brain Foundation Synchrony Symposium on Autism Spectrum Disorder
  3. December 2, 2021—Zoom lecture, “Programmed transformations in mitochondrial function in healing”. NIH Symposium: Mitochondrial Dysfunction as a Universal Driver for Increased Health Risks: from COVID to COSMOS.
  4. October 28-31, 2021—”The cell danger response and the rising tide of chronic disease”. Clinical and Scientific Insights (CASI) Conference, Designs for Health, Phoenix, AZ.
  5. October 14-16, 2021—”Exposome-metabolome interactions in autism spectrum disorder”. Duke University.
  6. June 3-5, 2021—”Exposome-metabolome interactions in chronic childhood and adult disorders”. IFM Zoom.
  7. June 3-5, 2021—”Exposome-metabolome interactions in chronic childhood and adult disorders”. IFM Zoom.
  8. May 14-16, 2021—”Exposome-metabolome interactions in autism spectrum disorder—The surprising effect of low-level environmental chemical exposures”. The MINDD Forum Zoom.
  9. April 21, 2021—”Environmental chemical effects on metabolism in health and disease. Is it safe to heal?” Hanscom Group Zoom.
  10. April 7, 2021—”Cell danger signaling, the healing cycle, and resilience”. Hanscom Group Zoom.
  11. November 8, 2020—”Autism metabolomics and the purinergic stress response”. Synchrony 2020—A virtual symposium sponsored by the Brain Foundation
  12. November 5-8, 2020—Clinical Applications of Scientific Innovation (CASI) symposium, Phoenix, AZ—Cancelled for COVID19
  13. October 9, 2020—“Lyme metabolomics–Updates from the Naviaux Lab”. A virtual meeting sponsored by LymeMIND and the Cohen foundation.
  14. October 9, 2020—”Mitochondrial targets and defenses in the time of COVID”. A virtual symposium sponsored by the United Mitochondrial Disease Foundation
  15. October 2, 2020—”Mitochondria, Autism, the Cell Danger Response, and a Suramin Update”. A virtual autism conference sponsored by TACA.
  16. September 13, 2020—22nd Annual UCSD Christini Fund Event. First ever virtual gala.
  17. June 24-27, 2020—Annual meeting of the United Mitochondrial Disease Foundation (UMDF), MMS, and MRS. Phoenix, AZ—Cancelled for COVID19
  18. March 19-21, 2020— Mitochondrial Blocks to Healing and Regeneration. Regenerative Medicine Workshop, Charleston, SC—Cancelled for COVID19
  19. November 8-10, 2019—ASTRA Meeting on Autism Treatment, Antipurinergic Therapy for Autism, San Francisco, CA
  20. October 18-20, 2019—TACA Annual Meeting, Antipurinergic therapy for Autism, Costa Mesa, CA
  21. October 4-5, 2019—Advances in Mitochondrial Medicine, The CDR and the Healing Cycle—A new model for chronic disease pathogenesis, Dallas, TX
  22. September 20-22, 2019—20th Anniversary Lyme Disease Association annual meeting, Providence, RI
  23. September 14, 2019—Origins of the CDR Hypothesis, San Diego, CA
  24. September 6-8, 2019—FDA Workshop on Drug Development and Clinical Trials for Mitochondrial Disease, Washington, DC
  25. All Past Events